Global Antisense & RNAi Therapeutics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 3798

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".
North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.
In 2018, the global Antisense & RNAi Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antisense & RNAi Therapeutics development in United States, Europe and China.

The key players covered in this study
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.

Market segment by Type, the product can be split into
RNA interference
SiRNA
MiRNA
Antisense RNA

Market segment by Application, split into
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Antisense & RNAi Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Antisense & RNAi Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Antisense & RNAi Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Antisense & RNAi Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 RNA interference
1.4.3 SiRNA
1.4.4 MiRNA
1.4.5 Antisense RNA
1.5 Market by Application
1.5.1 Global Antisense & RNAi Therapeutics Market Share by Application (2014-2025)
1.5.2 Oncology
1.5.3 Cardiovascular
1.5.4 Renal
1.5.5 Neurodegenerative
1.5.6 Respiratory
1.5.7 Genetic
1.5.8 Infectious Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Antisense & RNAi Therapeutics Market Size
2.2 Antisense & RNAi Therapeutics Growth Trends by Regions
2.2.1 Antisense & RNAi Therapeutics Market Size by Regions (2014-2025)
2.2.2 Antisense & RNAi Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Antisense & RNAi Therapeutics Market Size by Manufacturers
3.1.1 Global Antisense & RNAi Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Antisense & RNAi Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Antisense & RNAi Therapeutics Key Players Head office and Area Served
3.3 Key Players Antisense & RNAi Therapeutics Product/Solution/Service
3.4 Date of Enter into Antisense & RNAi Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Antisense & RNAi Therapeutics Market Size by Type (2014-2019)
4.2 Global Antisense & RNAi Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Antisense & RNAi Therapeutics Market Size (2014-2019)
5.2 Antisense & RNAi Therapeutics Key Players in United States
5.3 United States Antisense & RNAi Therapeutics Market Size by Type
5.4 United States Antisense & RNAi Therapeutics Market Size by Application

6 Europe
6.1 Europe Antisense & RNAi Therapeutics Market Size (2014-2019)
6.2 Antisense & RNAi Therapeutics Key Players in Europe
6.3 Europe Antisense & RNAi Therapeutics Market Size by Type
6.4 Europe Antisense & RNAi Therapeutics Market Size by Application

7 China
7.1 China Antisense & RNAi Therapeutics Market Size (2014-2019)
7.2 Antisense & RNAi Therapeutics Key Players in China
7.3 China Antisense & RNAi Therapeutics Market Size by Type
7.4 China Antisense & RNAi Therapeutics Market Size by Application

8 Japan
8.1 Japan Antisense & RNAi Therapeutics Market Size (2014-2019)
8.2 Antisense & RNAi Therapeutics Key Players in Japan
8.3 Japan Antisense & RNAi Therapeutics Market Size by Type
8.4 Japan Antisense & RNAi Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Antisense & RNAi Therapeutics Market Size (2014-2019)
9.2 Antisense & RNAi Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Antisense & RNAi Therapeutics Market Size by Type
9.4 Southeast Asia Antisense & RNAi Therapeutics Market Size by Application

10 India
10.1 India Antisense & RNAi Therapeutics Market Size (2014-2019)
10.2 Antisense & RNAi Therapeutics Key Players in India
10.3 India Antisense & RNAi Therapeutics Market Size by Type
10.4 India Antisense & RNAi Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Antisense & RNAi Therapeutics Market Size (2014-2019)
11.2 Antisense & RNAi Therapeutics Key Players in Central & South America
11.3 Central & South America Antisense & RNAi Therapeutics Market Size by Type
11.4 Central & South America Antisense & RNAi Therapeutics Market Size by Application

12 International Players Profiles
12.1 Glaxo Smith Kline
12.1.1 Glaxo Smith Kline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Antisense & RNAi Therapeutics Introduction
12.1.4 Glaxo Smith Kline Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.1.5 Glaxo Smith Kline Recent Development
12.2 Sanofi Aventis / Genzyme
12.2.1 Sanofi Aventis / Genzyme Company Details
12.2.2 Company Description and Business Overview
12.2.3 Antisense & RNAi Therapeutics Introduction
12.2.4 Sanofi Aventis / Genzyme Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.2.5 Sanofi Aventis / Genzyme Recent Development
12.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
12.3.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Antisense & RNAi Therapeutics Introduction
12.3.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.3.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Recent Development
12.4 Arbutus Biopharma Ltd.
12.4.1 Arbutus Biopharma Ltd. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Antisense & RNAi Therapeutics Introduction
12.4.4 Arbutus Biopharma Ltd. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.4.5 Arbutus Biopharma Ltd. Recent Development
12.5 Silence Therapeutics
12.5.1 Silence Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Antisense & RNAi Therapeutics Introduction
12.5.4 Silence Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.5.5 Silence Therapeutics Recent Development
12.6 Bio-Path Holdings Inc.
12.6.1 Bio-Path Holdings Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Antisense & RNAi Therapeutics Introduction
12.6.4 Bio-Path Holdings Inc. Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.6.5 Bio-Path Holdings Inc. Recent Development
12.7 Calando Pharmaceuticals
12.7.1 Calando Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Antisense & RNAi Therapeutics Introduction
12.7.4 Calando Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.7.5 Calando Pharmaceuticals Recent Development
12.8 ICo Therapeutics
12.8.1 ICo Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Antisense & RNAi Therapeutics Introduction
12.8.4 ICo Therapeutics Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.8.5 ICo Therapeutics Recent Development
12.9 Quark Pharmaceuticals
12.9.1 Quark Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Antisense & RNAi Therapeutics Introduction
12.9.4 Quark Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.9.5 Quark Pharmaceuticals Recent Development
12.10 Rexhan Pharmaceuticals
12.10.1 Rexhan Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Antisense & RNAi Therapeutics Introduction
12.10.4 Rexhan Pharmaceuticals Revenue in Antisense & RNAi Therapeutics Business (2014-2019)
12.10.5 Rexhan Pharmaceuticals Recent Development
12.11 Biomarin/Prosensa
12.12 Regulus Therapeutics
12.13 Rxi Pharmaceuticals
12.14 Silenseed
12.15 Dicerna Pharmaceuticals
12.16 Sirnaomics Inc.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details